ALEXANDRIA, Va., Aug. 12 -- United States Patent no. 12,383,507, issued on Aug. 12, was assigned to CHIESI FARMACEUTICI S.P.A. (Parma, Italy).
"Clevidipine nanoparticles and pharmaceutical compositions thereof" was invented by Rajeshwar Motheram (Dayton, Ohio), David Hanley (Brookfield, Conn.), Akif Emre Tureli (Saarlouis, Germany) and Monika Kanter (Saarburg, Germany).
According to the abstract* released by the U.S. Patent & Trademark Office: "Provided is a pharmaceutical composition comprising clevidipine in a sterile, ready to use, physically stable, aqueous dispersion of nanoparticles that stabilizes clevidipine against formation of impurities and is suitable for parenteral administration."
The patent was filed on Nov. 29, 2022, unde...